![Paul Schaffer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Paul Schaffer
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARTMS, Inc.
![]() ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Director Técnico/Científico/I+D | 28/03/2018 | - |
Director Ejecutivo | - | 28/03/2018 |
Historial de carrera de Paul Schaffer
Antiguos cargos conocidos de Paul Schaffer.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Centre For Probe Development & Commercialization
![]() Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Director/Miembro de la Junta | 01/01/2018 | 17/06/2021 |
Estadísticas
Internacional
Canadá | 3 |
Operativa
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
ARTMS, Inc.
![]() ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Health Technology |
Centre For Probe Development & Commercialization
![]() Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Schaffer
- Experiencia